JP2002538207A5 - - Google Patents

Download PDF

Info

Publication number
JP2002538207A5
JP2002538207A5 JP2000603671A JP2000603671A JP2002538207A5 JP 2002538207 A5 JP2002538207 A5 JP 2002538207A5 JP 2000603671 A JP2000603671 A JP 2000603671A JP 2000603671 A JP2000603671 A JP 2000603671A JP 2002538207 A5 JP2002538207 A5 JP 2002538207A5
Authority
JP
Japan
Prior art keywords
multiple sclerosis
cyclopropylmethoxy
difluoromethoxy
benzamide
dichloropyrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000603671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002538207A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/001703 external-priority patent/WO2000053182A2/en
Publication of JP2002538207A publication Critical patent/JP2002538207A/ja
Publication of JP2002538207A5 publication Critical patent/JP2002538207A5/ja
Pending legal-status Critical Current

Links

JP2000603671A 1999-03-10 2000-03-01 多発性硬化症治療のための3−シクロプロピルメトキシ−4−ジフルオロメトキシ−n−(3,5−ジクロロピリド−4−イル)ベンズアミド Pending JP2002538207A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99104793 1999-03-10
EP99104793.7 1999-03-10
PCT/EP2000/001703 WO2000053182A2 (en) 1999-03-10 2000-03-01 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis

Publications (2)

Publication Number Publication Date
JP2002538207A JP2002538207A (ja) 2002-11-12
JP2002538207A5 true JP2002538207A5 (cg-RX-API-DMAC10.html) 2007-05-10

Family

ID=8237737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000603671A Pending JP2002538207A (ja) 1999-03-10 2000-03-01 多発性硬化症治療のための3−シクロプロピルメトキシ−4−ジフルオロメトキシ−n−(3,5−ジクロロピリド−4−イル)ベンズアミド

Country Status (12)

Country Link
US (1) US6531493B1 (cg-RX-API-DMAC10.html)
EP (1) EP1161239B1 (cg-RX-API-DMAC10.html)
JP (1) JP2002538207A (cg-RX-API-DMAC10.html)
AT (1) ATE279924T1 (cg-RX-API-DMAC10.html)
AU (1) AU3284000A (cg-RX-API-DMAC10.html)
CA (1) CA2364258C (cg-RX-API-DMAC10.html)
DE (1) DE60015098T2 (cg-RX-API-DMAC10.html)
DK (1) DK1161239T3 (cg-RX-API-DMAC10.html)
ES (1) ES2231162T3 (cg-RX-API-DMAC10.html)
PT (1) PT1161239E (cg-RX-API-DMAC10.html)
SI (1) SI1161239T1 (cg-RX-API-DMAC10.html)
WO (1) WO2000053182A2 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
US20030092706A1 (en) * 2001-11-09 2003-05-15 Johannes Barsig Combination
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US20060084684A1 (en) 2002-05-28 2006-04-20 Altana Pharma Ag Topically applicable pharmaceutical preparation
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
DE102004046235A1 (de) 2004-09-22 2006-03-30 Altana Pharma Ag Arzneimittelzubereitung
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106517A0 (en) 1992-07-28 1994-08-26 Rhone Poulenc Rorer Ltd Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic or heteroatom containing linking group
CZ290266B6 (cs) * 1993-07-02 2002-06-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituované benzamidy, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
DE69532238T2 (de) * 1994-04-21 2004-10-21 Schering Ag Pde iv-inhibitoren zur behandlung der multiplen sklerose

Similar Documents

Publication Publication Date Title
KR101408315B1 (ko) 다층 경구 붕해 정제
TW466119B (en) Film coated tablet of paracetamol and domperidone
JP5973411B2 (ja) 医薬組成物
CA2918576C (en) Immediate release analgesic and antiemetic combination compositions
JP3874793B2 (ja) イブプロフェンおよびコデイン含有の改良された医薬処方
UA76417C2 (en) Pharmaceutical composition comprising immediate release phase and sustained release phase of paracetamol
JP2004519440A (ja) アムロジピンとベナゼプリル/ベナゼプリラートの治療上の組み合せ
JP2002528502A5 (cg-RX-API-DMAC10.html)
JP2002520362A5 (cg-RX-API-DMAC10.html)
JP2005508963A5 (cg-RX-API-DMAC10.html)
WO2001080619A3 (en) Pharmaceutical composition containing citalopram
JPS6357405B2 (cg-RX-API-DMAC10.html)
WO2002067905A1 (en) A sustained release pharmaceutical formulation
JP2003523385A5 (cg-RX-API-DMAC10.html)
EP2046300B1 (en) Multilayer orally disintegrating tablet
KR20070069175A (ko) 구강 내 용해용 고형 제제
JP2000344665A (ja) 鎮痛剤
JP2007513095A5 (cg-RX-API-DMAC10.html)
RU2174836C1 (ru) Фармацевтическая композиция, обладающая анальгезирующим действием
RU2006122160A (ru) Пероральное лекарственное средство для восполнения дефицита магния в организме
WO2021150178A1 (en) Pharmaceutical compositions comprising ibuprofen, pseudoephedrine and ascorbic acid
JP2005527634A (ja) 緊張型頭痛の治療にミルナシプランを使用する方法
RU2008100280A (ru) Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
JPS58174317A (ja) ジベンゾシクロヘプタジエンとコデルゴクリンを含有する薬学的組成物
HK1128881B (en) Multilayer orally disintegrating tablet